Schaper Benz & Wise Investment Counsel Inc. WI lifted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 197,832 shares of the pharmacy operator’s stock after purchasing an additional 130 shares during the quarter. Walgreens Boots Alliance accounts for about 2.5% of Schaper Benz & Wise Investment Counsel Inc. WI’s portfolio, making the stock its 7th biggest position. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Walgreens Boots Alliance were worth $15,492,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in WBA. Reilly Financial Advisors LLC raised its position in Walgreens Boots Alliance by 7.9% in the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after buying an additional 100 shares during the last quarter. Orrstown Financial Services Inc. raised its position in Walgreens Boots Alliance by 14.1% in the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after buying an additional 213 shares during the last quarter. Founders Capital Management acquired a new stake in Walgreens Boots Alliance in the 1st quarter valued at approximately $161,000. Modera Wealth Management LLC raised its position in Walgreens Boots Alliance by 0.4% in the 1st quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock valued at $204,000 after buying an additional 9 shares during the last quarter. Finally, Schaller Investment Group Inc. acquired a new stake in Walgreens Boots Alliance in the 1st quarter valued at approximately $208,000. 60.14% of the stock is currently owned by institutional investors.

Shares of Walgreens Boots Alliance, Inc. (WBA) opened at 68.06 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $66.92 and a 1-year high of $89.69. The company has a 50-day moving average price of $76.37 and a 200 day moving average price of $80.09. The company has a market capitalization of $72.83 billion, a P/E ratio of 17.19 and a beta of 1.25.

Walgreens Boots Alliance declared that its Board of Directors has authorized a stock repurchase plan on Thursday, June 29th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase up to 5.9% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its shares are undervalued.

A number of brokerages recently issued reports on WBA. Needham & Company LLC set a $94.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Monday, July 17th. Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Sunday, July 2nd. Guggenheim reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Morgan Stanley reaffirmed an “overweight” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Finally, Citigroup Inc. reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the company. Walgreens Boots Alliance has a consensus rating of “Buy” and a consensus price target of $89.24.

TRADEMARK VIOLATION WARNING: This story was posted by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.watchlistnews.com/schaper-benz-wise-investment-counsel-inc-wi-grows-stake-in-walgreens-boots-alliance-inc-wba/1646918.html.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the transaction, the director now directly owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.